Brain Tech Startup Science Corp. Raises $230 Million to Treat Blindness

A 3D rendering of Science’s retina implant PRIMA, a chip that sits at the back of the eye and helps blind people see, with the assistance of a special pair of glasses that projects images into the eye.Source: Science Corp.

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Ike Swetlitz

March 5, 2026 at 1:45 PM UTC

Updated on

March 5, 2026 at 3:00 PM UTC

Neurotechnology company Science Corp. raised $230 million from investors to commercialize its implant for blindness and develop even more advanced brain devices.

The fundraising brings Science’s valuation to $1.5 billion, including the new money, according to a person familiar with the matter, who wasn’t authorized to speak publicly. That makes it the second-most valuable brain implant company after Neuralink, Elon Musk’s startup. It’s also the second-most well-funded, having raised a total of $489 million to date.